Hexylcaine 4883632 161053229 2007-09-29T04:01:33Z Shoy 459990 Fixing image for image move to commons {{drugbox | IUPAC_name = 1-cyclohexylaminopropan-2-yl benzoate | image = Hexylcaine.PNG | CAS_number = 532-77-4 | ATC_prefix = | ATC_suffix = | ATC_supplemental = | PubChem = 10770 | DrugBank = APRD01014 | C = 16 | H = 23 | N = 1 | O = 2 | molecular_weight = 261.359 g/mol | bioavailability = | protein_bound = | metabolism = | elimination_half-life = <10 minutes | pregnancy_category = | legal_status = | routes_of_administration = }} '''Hexylcaine hydrochloride''', also called '''cyclaine''' ([[Merck & Co.|Merck]]) or '''osmocaine''', is a short-acting [[local anesthetic]]. It acts by inhibiting [[sodium channel]] conduction. Overdose can lead to [[headache]], [[tinnitus]], [[paresthesia|numbness and tingling]] around the mouth and tongue, [[convulsion]]s, [[respiratory arrest|inability to breathe]], and decreased heart function. {{Local anesthetics}} [[Category:Local anesthetics]] {{pharma-stub}}